Logo image of MARR.MI

MARR SPA (MARR.MI) Stock Fundamental Analysis

BIT:MARR - Euronext Milan - IT0003428445 - Common Stock - Currency: EUR

9.64  +0.24 (+2.55%)

Fundamental Rating

4

Overall MARR gets a fundamental rating of 4 out of 10. We evaluated MARR against 23 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and the financial health of MARR get a neutral evaluation. Nothing too spectacular is happening here. MARR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MARR had positive earnings in the past year.
In the past year MARR had a positive cash flow from operations.
Of the past 5 years MARR 4 years were profitable.
MARR had a positive operating cash flow in 4 of the past 5 years.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

MARR's Return On Assets of 3.98% is in line compared to the rest of the industry. MARR outperforms 56.52% of its industry peers.
Looking at the Return On Equity, with a value of 17.04%, MARR is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
MARR's Return On Invested Capital of 9.46% is fine compared to the rest of the industry. MARR outperforms 65.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MARR is below the industry average of 9.50%.
The last Return On Invested Capital (9.46%) for MARR is above the 3 year average (6.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.98%
ROE 17.04%
ROIC 9.46%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 1.76%, MARR is in line with its industry, outperforming 43.48% of the companies in the same industry.
MARR's Profit Margin has declined in the last couple of years.
MARR's Operating Margin of 3.09% is on the low side compared to the rest of the industry. MARR is outperformed by 60.87% of its industry peers.
In the last couple of years the Operating Margin of MARR has declined.
MARR has a Gross Margin of 7.74%. This is amonst the worse of the industry: MARR underperforms 91.30% of its industry peers.
In the last couple of years the Gross Margin of MARR has grown nicely.
Industry RankSector Rank
OM 3.09%
PM (TTM) 1.76%
GM 7.74%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MARR is creating some value.
The number of shares outstanding for MARR has been reduced compared to 1 year ago.
The number of shares outstanding for MARR has been reduced compared to 5 years ago.
The debt/assets ratio for MARR has remained at the same level compared to a year ago.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MARR has an Altman-Z score of 3.36. This indicates that MARR is financially healthy and has little risk of bankruptcy at the moment.
MARR has a Altman-Z score of 3.36. This is in the better half of the industry: MARR outperforms 69.57% of its industry peers.
MARR has a debt to FCF ratio of 27.61. This is a negative value and a sign of low solvency as MARR would need 27.61 years to pay back of all of its debts.
With a Debt to FCF ratio value of 27.61, MARR is not doing good in the industry: 82.61% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.14 is on the high side and indicates that MARR has dependencies on debt financing.
MARR has a Debt to Equity ratio of 1.14. This is comparable to the rest of the industry: MARR outperforms 43.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.61
Altman-Z 3.36
ROIC/WACC1.51
WACC6.27%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

MARR has a Current Ratio of 1.44. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
MARR's Current ratio of 1.44 is amongst the best of the industry. MARR outperforms 86.96% of its industry peers.
MARR has a Quick Ratio of 1.02. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MARR (1.02) is better than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.02
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for MARR have decreased strongly by -21.35% in the last year.
MARR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.05% yearly.
Looking at the last year, MARR shows a small growth in Revenue. The Revenue has grown by 0.56% in the last year.
MARR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)-21.35%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-27.17%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%0.97%

3.2 Future

MARR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.54% yearly.
MARR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.62% yearly.
EPS Next Y12.03%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
EPS Next 5YN/A
Revenue Next Year2.44%
Revenue Next 2Y2.85%
Revenue Next 3Y3.26%
Revenue Next 5Y3.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.61, the valuation of MARR can be described as very reasonable.
Based on the Price/Earnings ratio, MARR is valued a bit cheaper than 69.57% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.85. MARR is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 11.87, the valuation of MARR can be described as very reasonable.
The rest of the industry has a similar Price/Forward Earnings ratio as MARR.
MARR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.98.
Industry RankSector Rank
PE 11.61
Fwd PE 11.87
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MARR is valued a bit more expensive than 60.87% of the companies in the same industry.
73.91% of the companies in the same industry are cheaper than MARR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.28
EV/EBITDA 7.87
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y11.57%
EPS Next 3Y11.54%

6

5. Dividend

5.1 Amount

MARR has a Yearly Dividend Yield of 6.44%, which is a nice return.
Compared to an average industry Dividend Yield of 4.15, MARR pays a better dividend. On top of this MARR pays more dividend than 91.30% of the companies listed in the same industry.
MARR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.44%

5.2 History

The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MARR pays out 71.68% of its income as dividend. This is not a sustainable payout ratio.
DP71.68%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR SPA

BIT:MARR (8/19/2025, 7:00:00 PM)

9.64

+0.24 (+2.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-14 2025-11-14
Inst Owners23.6%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap641.35M
Analysts78.33
Price Target12.56 (30.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.44%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP71.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 11.61
Fwd PE 11.87
P/S 0.21
P/FCF 34.28
P/OCF 11.98
P/B 2.03
P/tB 4.4
EV/EBITDA 7.87
EPS(TTM)0.83
EY8.61%
EPS(NY)0.81
Fwd EY8.43%
FCF(TTM)0.28
FCFY2.92%
OCF(TTM)0.8
OCFY8.35%
SpS45.79
BVpS4.74
TBVpS2.19
PEG (NY)0.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.98%
ROE 17.04%
ROCE 13.54%
ROIC 9.46%
ROICexc 13.6%
ROICexgc 20.95%
OM 3.09%
PM (TTM) 1.76%
GM 7.74%
FCFM 0.61%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
ROICexc(3y)9.5%
ROICexc(5y)7.64%
ROICexgc(3y)14.76%
ROICexgc(5y)12.13%
ROCE(3y)9.43%
ROCE(5y)7.37%
ROICexcg growth 3Y-2.5%
ROICexcg growth 5Y-13.81%
ROICexc growth 3Y0.65%
ROICexc growth 5Y-11.99%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
F-Score3
Asset Turnover2.26
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.61
Debt/EBITDA 3.03
Cap/Depr 144.76%
Cap/Sales 1.14%
Interest Coverage 250
Cash Conversion 45.32%
Profit Quality 34.81%
Current Ratio 1.44
Quick Ratio 1.02
Altman-Z 3.36
F-Score3
WACC6.27%
ROIC/WACC1.51
Cap/Depr(3y)107.37%
Cap/Depr(5y)94.25%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.35%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-27.17%
EPS Next Y12.03%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
EPS Next 5YN/A
Revenue 1Y (TTM)0.56%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%0.97%
Revenue Next Year2.44%
Revenue Next 2Y2.85%
Revenue Next 3Y3.26%
Revenue Next 5Y3.62%
EBIT growth 1Y-23.54%
EBIT growth 3Y7.4%
EBIT growth 5Y-6.98%
EBIT Next Year52.54%
EBIT Next 3Y22.77%
EBIT Next 5YN/A
FCF growth 1Y27.25%
FCF growth 3Y-31.25%
FCF growth 5Y-12.02%
OCF growth 1Y41.34%
OCF growth 3Y-19.18%
OCF growth 5Y-3.88%